A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

被引：0
|
作者：
Alice Maier
Anita Dharan
Gina Oliver
Michael Berk
Suzy Redston
Sudie E. Back
Peter Kalivas
Chee Ng
Richard A. Kanaan
机构：
[1] University of Melbourne,Department of Psychiatry, Austin Health
[2] University of Melbourne,Department of Psychiatry, The Melbourne Clinic
[3] Deakin University,IMPACT – the Institute for Mental and Physical Health and Clinical Translation, School of Medicine
[4] Barwon Health,Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry
[5] The University of Melbourne,Department of Psychiatry and Behavioral Sciences
[6] Austin Health,Department of Neuroscience
[7] Medical University of South Carolina; Ralph H. Johnson VA Medical Center,undefined
[8] Medical University of South Carolina,undefined
[9] Ralph H Johnson VA Medical Center,undefined
来源：
BMC Psychiatry | / 20卷
关键词：
Clinical trial protocol; N-acetyl cysteine; Post-traumatic stress disorder; N-acetyl cysteine; Adjunctive therapy; Randomised clinical trial; Oxidative stress; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [32] Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: A 12-week, double-blind, placebo-controlled trial
    Lee, J. G.
    Kim, Y. -H.
    Lee, S. W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 141 - 142
  • [33] Tavipec® in acute rhinosinusitis: a multi-centre, double-blind, randomized, placebo-controlled, clinical trial
    Dejaco, Daniel
    Bocian-Sobkowska, Joanna
    Szymanski, Witold
    Zacke, Gabriele
    Hoeckner, Verena
    Riechelmann, Herbert
    RHINOLOGY, 2019, 57 (05) : 367 - 374
  • [34] Botulinum toxin as a preventive treatment for migraine:: a randomized double-blind placebo-controlled multi-centre study
    Petri, S
    Tölle, T
    Pfaffenrath, V
    Stefenelli, U
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S89 - S89
  • [35] Efficacy and neurochemical effects of adjunctive cytidine supplementation in treating bipolar depression: 12-week results from a randomized, double-blind, placebo-controlled trial
    Yoon, Sujung J.
    Lyoo, In Kyoon
    Cohen, Bruce M.
    Renshaw, Perry F.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 242S - 242S
  • [36] Risperidone for severe tardive dyskinesia: A 12-week randomized, double-blind, placebo-controlled study
    Bai, YM
    Yu, SC
    Lin, CC
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1342 - 1348
  • [37] A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics, for the cognitive impairments in chronic schizophrenia
    Lee, Sae-Woom
    Lee, Jung-Goo
    Lee, Bong-Ju
    Kim, Young Hoon
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 63 - 68
  • [38] EFFICACY, SAFETY AND TOLERABILITY OF BREXPIPRAZOLE FOR THE TREATMENT OF AGITATION IN ALZHEIMER'S DEMENTIA: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Grossberg, George
    Lee, Daniel
    Slomkowski, Mary
    Hefting, Nanco
    Chen, Dalei
    Larsen, Groes
    Kohegyi, Eva
    Hobart, Mary
    Cummings, Jeffrey
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S99 - S100
  • [39] A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder
    Gharabawi, G. M.
    Canuso, C. M.
    Pandina, G. J.
    Bossie, C. A.
    Kujawa, M.
    Kosik-Gonzalez, C.
    Turkoz, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S562 - S562
  • [40] A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder
    Gharabawi, G.
    Canuso, C.
    Pandina, G.
    Bossie, C.
    Kujawa, M.
    Kosik-Gonzalez, C.
    Turkoz, I.
    Papakostas, G. I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S236 - S236
12345